Article
Targeted gene delivery of <i>BMPR2</i> attenuates pulmonary hypertension
7 Jul 2011
Abstract excerpt
Pulmonary arterial hypertension (PAH) remains a fatal disease despite modern pharmacotherapy. Mutations in the gene for bone morphogenetic protein receptor type II (BMPR2) lead to reduced BMPR2 expression, which is causally linked to PAH. BMPR2 is predominantly expressed on pulmonary endothelium and has complex interactions with transforming growth factor (TGF)-β signalling mechanisms. Our objectives were to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
